News

manilatimes6d
Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European ...
June 15, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today ...
pharmaphorum5d
Pfizer/BioNTech begin phase 1 of COVID-19/influenza combo
BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate a single dose mRNA-based combination vaccine candidate against influenza and COVID-19 – a novel ...
Honest John on MSN3d
Peugeot e-208 GTI 2026: Prices, specs and release date
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The Lancet6d
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
Copyright: © 2022 Elsevier Ltd. All rights reserved.